Heczey, Andras http://orcid.org/0000-0002-4263-9115
Courtney, Amy N.
Montalbano, Antonino
Robinson, Simon
Liu, Ka http://orcid.org/0000-0003-4029-8852
Li, Mingmei
Ghatwai, Nisha
Dakhova, Olga
Liu, Bin
Raveh-Sadka, Tali
Chauvin-Fleurence, Cynthia N. http://orcid.org/0000-0001-6425-8543
Xu, Xin http://orcid.org/0000-0002-9485-8782
Ngai, Ho
Di Pierro, Erica J.
Savoldo, Barbara
Dotti, Gianpietro http://orcid.org/0000-0002-2639-8526
Metelitsa, Leonid S. http://orcid.org/0000-0002-9639-6630
Funding for this research was provided by:
Alex’s Lemonade Stand Foundation for Childhood Cancer
Kuur Therapeutics; Cookies for Kids’ Cancer Foundation
American Cancer Society
Kuur Therapeutics
Cancer Prevention and Research Institute of Texas (RP160283)
Article History
Received: 10 March 2020
Accepted: 21 August 2020
First Online: 12 October 2020
Competing interests
: A.H., A.N.C., G.D. and L.S.M are co-inventors on pending patent applications that relate to the use of NKT cells in cancer immunotherapy and have been licensed by Baylor College of Medicine to Kuur Therapeutics for commercial development. Kuur Therapeutics provided research support for this project (to L.S.M.) via a sponsored research agreement with Baylor College of Medicine. A.M., S.R., K.L., M.L., N.G., O.D., B.L., T.R.-S., C.N.C.-F., X.X., H.N., E.J.D.P. and B.S. declare no competing financial interests.